Ionic products of bioactive glass dissolution increase proliferation of human osteoblasts and induce insulin-like growth factor II mRNA expression and protein synthesis

被引:918
作者
Xynos, ID
Edgar, AJ
Buttery, LDK
Hench, LL
Polak, JM
机构
[1] Univ London Imperial Coll Sci Technol & Med, Sch Med, Dept Histochem, London W12 0NN, England
[2] Univ London Imperial Coll Sci Technol & Med, Tissue Engn Ctr, London W12 0NN, England
[3] Univ London Imperial Coll Sci Technol & Med, Dept Mat, London W12 0NN, England
基金
英国医学研究理事会;
关键词
human osteoblasts; osteogenesis; bioactive glass; silicon; IGF-II; IGFBP-3; MMP-2; cathepsin-D;
D O I
10.1006/bbrc.2000.3503
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 [生物化学与分子生物学]; 081704 [应用化学];
摘要
Bioglass 45S5 is an osteoproductive material, which resorbs by releasing its constitutive ions into solution. Treatment with the ionic products of Bioglass 45S5 dissolution in DMEM for 4 days increased human osteoblast proliferation to 155% of control, Two days after treatment, differential gene expression was analyzed by cDNA microarrays, Expression of a potent osteoblast mitogenic growth factor, insulin-like growth factor II (IGF-II), was increased to 290%, Additionally, there was a 168% increase in the concentration of unbound IGF-II protein in the conditioned media of treated osteoblasts. Expression levels of IGFBP-3, an IGF-II carrier protein, metalloproteinase-2 and cathepsin-D were also increased to 200, 340, and 310% of central levels, respectively. Metalloproteinase-2 and cathepsin-D are proteases that cleave IGF-II from its carrier proteins, resulting in the release of the unbound biologically active IGF-II. We suggest that the stimulatory effect of the ionic products of Bioglass 45S5 dissolution on osteoblast proliferation may be mediated by IGF-II. (C) 2000 Academic Press.
引用
收藏
页码:461 / 465
页数:5
相关论文
共 36 条
[1]
INSULIN-LIKE GROWTH-FACTOR GENE-EXPRESSION IN HUMAN FRACTURE CALLUS [J].
ANDREW, JG ;
HOYLAND, J ;
FREEMONT, AJ ;
MARSH, D .
CALCIFIED TISSUE INTERNATIONAL, 1993, 53 (02) :97-102
[2]
INSULIN-LIKE GROWTH FACTOR-I AND FACTOR-II ARE PRESENT IN THE SKELETAL TISSUES OF 10 VERTEBRATES [J].
BAUTISTA, CM ;
MOHAN, S ;
BAYLINK, DJ .
METABOLISM-CLINICAL AND EXPERIMENTAL, 1990, 39 (01) :96-100
[3]
PRODUCTION OF OSTEOCALCIN BY HUMAN-BONE CELLS-INVITRO - EFFECTS OF 1,25(OH)2D3, 24,25(OH)2D3, PARATHYROID-HORMONE, AND GLUCOCORTICOIDS [J].
BERESFORD, JN ;
GALLAGHER, JA ;
POSER, JW ;
RUSSELL, RGG .
METABOLIC BONE DISEASE & RELATED RESEARCH, 1984, 5 (05) :229-234
[4]
BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3
[5]
Bradley JP, 1999, PLAST RECONSTR SURG, V104, P129, DOI 10.1097/00006534-199907000-00018
[6]
Chen Y, 1998, J CELL BIOCHEM, V71, P351, DOI 10.1002/(SICI)1097-4644(19981201)71:3<351::AID-JCB4>3.0.CO
[7]
2-5
[8]
CONOVER CA, 1994, J BIOL CHEM, V269, P7076
[9]
CONOVER CA, 1996, CELLULAR MOL BIOL BO, P607
[10]
BONE TISSUE ENGINEERING [J].
CRANE, GM ;
ISHAUG, SL ;
MIKOS, AG .
NATURE MEDICINE, 1995, 1 (12) :1322-1324